Connect with us

Emerging Markets

Genesis Electronics Group, Inc. (OTCMKTS: GEGI) Breakout into Copperland as Autonomous Vehicles Reverse Merger Runner Beefs up BOD with Industry Professionals

Published

on

Genesis Electronics Group, Inc. (OTCMKTS: GEGI) is continuing higher in recent trading rocketing over 52 wee highs and well into copperland as this autonomous EV reverse merger runner gains traction. We first reported on GEGI in June when the stock was around $0.003 and it has quadrupled since then and looks like it’s just getting started. Earlier this year GEGI recently completed a change of control whereby the Company created 1,000 shares of Series A Preferred stock and issued the shares to Braden Jones, the new CEO giving him 51% of the total voting power of the Company’s common shareholders. The Series A Preferred stock is not convertible into shares of common stock. Currently GEGI is on a blue sky breakout having surpassed all recent highs.

Reverse merger stocks can be more explosive than biotech’s when the incoming Company has real value but is undiscovered to investors and we have covered many on the website that have gone from pennies to dollars. Two recent RM runners that stand out are TSNP which went from sub pennies (where we first wrote about it) to over $6 per share. The other is HRBR which went from a few cents (where we first wrote about it) to $3 plus. There are a lot of exciting things happening at GEGI including the new business plan and website suggesting the Company is moving into the booming Artificial intelligence AI, autonomous vehicles space. GEGI has also been beefing up its BOD bringing on Aviation & Aerospace veteran Kevin Damoa and autonomous EV industry veteran Kasey Evans who is a board member at Einride, trading at a $1.2 billion market valuation and leading the autonomous EV space. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Genesis Electronics Group, Inc. (OTCMKTS: GEGI) is assembling a team of autonomous experts to identify companies and/or technologies that can be acquired and applied to specific industries that are ripe for disruption. There is a lot happening with GEGI, the Company recently launched a new website (https://www.genesis-electronics.com/) That it will continue to evolve as its vision narrows within this industry. In addition, the Company has established a formal corporate Twitter account to better communicate with its shareholders and the public. That Twitter handle is: @GenesisElectro4. Genesis plans to file all of its required disclosures as soon as the OTC Markets completes their change of control process and allows access to the OTCiq system. At that time management anticipates all yield signs to be removed and for the Company to be current again. 

Following a debt restructuring as well as resolving a dispute with a former debtor of the Company leaving GEGI in position where it can now use its stock to look for exciting and new business ventures, Katharina Nanny Bahnsen announced her resignation as Chairwoman, CEO, and was replaced by incoming CEO Braden Jones. 

In May Genesis launched a new business plan focusing on acquisitions or license agreements with autonomous technology companies. The Company plans to focus on identifying companies and/or technologies in industries such as transportation, security, flight, and artificial intelligence where autonomous technologies will be an explosive accelerator to new business growth. New CEO Braden Jones said at the time: “I am very excited to finally be able to reveal the new focus for Genesis Electronics Group. Since I was appointed as CEO of the Company, there were a lot of corporate housekeeping items that needed to take place so that we can move forward with our business plan. The settlement with the past judgement holder was extremely valuable as it freed up the Company to actively grow the business and provide greater shareholder value. We have been working very hard to refine our business plan and we believe that focusing on autonomous technologies will bring the greatest value to our shareholders. Autonomous technology has rapidly advanced over the past 10 years and there are so many industries that can be disrupted if these technologies were applied to them. We are assembling a highly-qualified team of advisors and partners that are making introductions to companies that could be good candidates for acquisition or licensing agreements. Their expertise and guidance have been extremely valuable thus far. We look forward to formalizing our relationships with these individuals and the Company and making these announcements in the near future, so their value can be felt by our shareholders.

According to Genesis new website: AUTONOMOUS TRANSPORTATION – The transportation industry is ripe for disruption. While many companies focus on autonomous cars and trucks, there is untapped potential where autonomous solutions can solve many logistics and transportation problems. 

AUTONOMOUS SECURITY – Autonomous solutions can drastically reduce costs and add much needed technology and support to current security solutions. Adding autonomous solutions to existing teams can increase efficiencies, decrease costs and save lives. 

ARTIFICIAL INTELLIGENCE – Autonomous solutions are only as good as the software and artificial intelligence behind the hardware. We are looking for tested and proven machine learning and artificial intelligence autonomous software that can be licensed or purchased to be leveraged in many applications. 

To Find out the inside Scoop on GEGI Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

GEGI

GEGI has been beefing up its BOD; in June GEGI added Kevin Damoa as a strategic advisor to the Board. Mr. Damoa is an experienced Operations Professional and military veteran with a demonstrated history of working in the Aviation & Aerospace, Electrification, E-Mobility, and Defense industries. Mr. Damoa has held critical leadership positions at early start ups and well-established corporations. His history includes Flight Module Logistics Management at SpaceX, Integration Project Manager at Northrop Grumann, Vice President at Romeo Power Technology, Vice President at XOS Trucks, Logistics & Safety Director at Canoo, and VP of Operations at Serial 1 Cycle Company.  Mr. Damoa is skilled in Operations Management, Program/Project Management, Compliance Engineering , Logistics Operations, Team Building, Organizational Leadership, and Mechanical/Structural Design. 

On August 29 GEGI announced that it has formally added Kasey Evans as a strategic advisor to the Board of the Company. Genesis Electronics Group ($GEGI) continues to add impressive advisors with unparalleled resumes in the autonomous industry. Mr Evans has worked closely with successful industry-leading companies such as XOS Trucks, Einride, Serial 1, and Vanderhall. Mr. Evans’ experience originally comes from the trucking and transportation industry where he held leadership roles at PACCAR, Pilot Thomas Logistics, and Autocar Trucks. He has worked with various venture capital firms and has become a seasoned investor in some of the hottest mobility innovation companies. Mr. Evans is an expert in rapid and sustainable growth. He is a dynamic and innovative leader experienced in sales, business development, negotiations, mergers & acquisitions, finance, asset management, expense reduction, and general management. 

Braden Jones, CEO stated: “We are so grateful and excited to have Kasey join our team as a strategic advisor. It is similar to a sports team; we understand the value of each player and seek for the very best to fill each position on the team. Kasey has connections across the globe, but more important is his ability to achieve goals which is evident throughout his work history. Kasey will be vital in the next steps of our business plan. We have a narrow focus and we hope to release a more detailed road map soon. We are continually inspired by the support and confidence of our shareholders.” 

https://twitter.com/DeepBlueEquity/status/1564673929931034624

For More on GEGI Subscribe Right Now!

Currently trading at a $19 million market valuation GEGI OS is 1,879,282,011 shares including the added 89 million restricted shares with just 307,072,424 shares in the float. GEGI does carry some debt on the books but not much at just under $2 million. GEGI is an exciting story developing in small caps, priced cheap with plenty of room for growth the stock is now running northbound on a blue sky breakout having eclipsed $0.0068 previous highs. There are a lot of exciting things happening at GEGI including the new CEO, business plan and website suggesting the Company is moving into the booming AI, autonomous vehicles space. GEGI has also been beefing up its BOD bringing on Aviation & Aerospace veteran Kevin Damoa and autonomous EV industry veteran Kasey Evans who is a board member at Einride, trading at a $1.2 billion market valuation and leading the autonomous EV space. Microcapdaily first covered GEGI in June when the stock was around $0.003 per share and we will be covering GEGI so make sure you subscribe to Microcapdaily right now.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in GEGI either long or short and we have not been compensated for this article.

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

on

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.